Skip to main content

Ryman Hospitality Properties, Inc. Announces First Quarter 2026 Earnings Conference Call – Friday, May 1, 2026, 10 a.m. ET

NASHVILLE, Tenn., March 11, 2026 (GLOBE NEWSWIRE) — Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and country music entertainment experiences, announced today that it will release its first quarter 2026 earnings results after the market closes on Thursday, April 30, 2026. Management will hold a conference call to discuss the quarter’s results at 10 a.m. ET on Friday, May 1, 2026. To participate in the conference call, please dial 800-225-9448 and use conference ID: RHPQ126. The call will be available for replay through May 8, 2026, by dialing 800-723-0607; a conference ID is not required. This call is also being webcast and can be accessed at the Company’s Investor Relations website...

Continue reading

Alpha Pro Tech, Ltd. Announces Fourth Quarter and Full Year 2025 Financial Results

Full Year 2025 Sales Increased to $59.1 Million, Up 2.3%, Compared to $57.8 Million for the Full Year of 2024Net sales for the year ended December 31, 2025, were $59.1 million, up 2.3% compared to $57.8 million for the year ended December 31, 2024 Net income for the year ended December 31, 2025, was $3.5 million, or $0.33 per diluted share, compared to $3.9 million, or $0.35 per diluted share, for the year ended December 31, 2024 Cash was $17.0 million and working capital was $48.5 million with no debt, as of December 31, 2025NOGALES, Ariz., March 11, 2026 (GLOBE NEWSWIRE) — Alpha Pro Tech, Ltd. (NYSE American: APT), a leading manufacturer of products designed to protect people, products and environments, including disposable protective apparel and building products, today announced financial results for the three month period...

Continue reading

Wealthfront Reports Fiscal Fourth Quarter and Full Year 2026 Results

Record annual revenue of $365.0 million in the fiscal year ending January 31, 2026,including a quarterly record of $96.1 million in the fiscal fourth quarter ending January 31, 2026Total Platform Assets up 17% year-over-year to a record $94.1 billion PALO ALTO, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Wealthfront Corporation (Nasdaq: WLTH), a tech-driven financial platform helping digital natives turn their savings into wealth, announced financial results for its fiscal fourth quarter and full year ended January 31, 2026. David Fortunato – CEO, President & Director: “We capped off a milestone year in the fourth quarter as we went public and drove another quarter-end record in Total Platform Assets due in large part to a second consecutive record quarter in net cross account transfers from Cash Management to Investment...

Continue reading

Foghorn Therapeutics Provides Financial Update for 2025 and 2026 Strategic Outlook

FHD-909 (LY4050784) Phase 1 dose-escalation advancing as planned, targeting SMARCA4 (BRG1)-mutant cancers with a focus on non-small cell lung cancer (NSCLC) Selective CBP degrader program with potential in ER+ breast cancer tracking to IND-enabling studies in 2026 Selective EP300 degrader program tracking to IND-enabling studies in 2026 with a focus in multiple myeloma (MM) and diffuse large b-cell lymphoma (DLBCL) Completed a $50 million registered direct financing in January 2026 Strong balance sheet with cash, cash equivalents, and marketable securities of $158.9 million as of December 31, 2025; with the addition of the January 2026 financing, the company has cash runway into the first half of 2028 WATERTOWN, Mass., March 11, 2026 (GLOBE NEWSWIRE) — Foghorn® Therapeutics Inc. (Nasdaq: FHTX), a clinical-stage biotechnology company...

Continue reading

Birchcliff Energy Ltd. Announces the Filing of its Audited Financial Statements and Other Disclosure Documents for the Year Ended December 31, 2025 and Provides Operational Update

CALGARY, Alberta, March 11, 2026 (GLOBE NEWSWIRE) — Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce that it has filed its audited annual financial statements (the “financial statements”) and related management’s discussion and analysis and its annual information form (the “AIF”) for the financial year ended December 31, 2025 (collectively, the “Annual Filings”). The AIF contains the reserves data and other oil and gas information as required by National Instrument 51-101 – Standards of Disclosure for Oil and Gas Activities. The financial and reserves information contained in the Annual Filings is consistent with the unaudited financial and reserves information disclosed in the press release issued by Birchcliff on February 11, 2026. The Annual Filings are available electronically on the...

Continue reading

Fossil Group, Inc. Reports Fourth Quarter and Full Year 2025 Results

Delivers financial performance above guidance ranges Full year 2025 worldwide net sales totaled $1 billion Full year gross margin expands 390 basis points to 56.1% Full year operating loss of $19 million and operating margin of (1.9)%; adjusted operating income of $12 million and adjusted operating margin of 1.1% Unveils next evolution of turnaround plan and raises long-term financial targetsRICHARDSON, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Fossil Group, Inc. (NASDAQ: FOSL) today announced financial results for the fourth quarter and fiscal year ended January 3, 2026. “The bold initiatives under the Turnaround Plan we announced one year ago gained traction quickly, enabling us to deliver operating and financial performance above our expectations for 2025,” said Franco Fogliato, CEO. “We focused on our core brands, channels...

Continue reading

Elutia Reports Fourth Quarter and Full Year 2025 Financial Results; Initiates NXT-41 Regulatory Process

– Base biologic matrix NXT-41 submitted to FDA; on track for anticipated FDA clearance in second half of 2026 and full NXT-41x clearance in 1H27 – – $44.4 million in cash and escrowed proceeds at year-end – – Conference call today at 5:00 p.m. ET / 2:00 p.m. PT – GAITHERSBURG, Md., March 11, 2026 (GLOBE NEWSWIRE) — Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix technologies, today provided a business update and financial results for the fourth quarter and full year ended December 31, 2025. Business Highlights:NXT-41x Development Program On Track: Elutia continues to advance development of NXT-41x, a next-generation antibiotic-eluting biomatrix for plastic and reconstructive surgery. The Company has submitted the 510(k) application for the base biologic matrix, NXT-41, to FDA and anticipates...

Continue reading

Codexis Reports Fourth Quarter and Fiscal Year 2025 Financial Results

     Q4 revenue of $38.9 million, total revenue of $70.4 million for the fiscal year ended December 31, 2025 Ended year with $78.2 million in cash, cash equivalents and short-term investments, runway through 2027 Completed $37.8 million Technology Transfer Agreement with Merck REDWOOD CITY, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today announced financial results for the fourth quarter and year ended December 31, 2025, and provided a business update. “Throughout 2025, we made significant strides in demonstrating the importance of our ECO Synthesis® Manufacturing Platform to customers in the RNAi industry. We’ve secured multiple contracts with leading pharma, high growth biotech, and top tier...

Continue reading

Exodus Reports Fourth Quarter 2025 Results with Record Full Year Revenue

B2B infrastructure continues to scale with record full year 2025 revenue of $121.6 million and full year swap volume up 21% to $6.89 billion OMAHA, Neb., March 11, 2026 (GLOBE NEWSWIRE) — Exodus Movement, Inc. (NYSE American: EXOD) (“Exodus” or the “Company”), the leading self-custodial cryptocurrency platform and first U.S. publicly traded company to tokenize its stock, today announced its results for the fourth quarter and full year ended December 31, 2025. The Company reported record full year revenue of $121.6 million for fiscal year 2025, an increase of 5% compared to fiscal year 2024, while full year swap volume grew 21% to $6.89 billion.Fourth Quarter and Full Year 2025 Financial Highlights (In USD millions, except percentages) Q4 2025   Q4 2024   % Change     2025     2024   % Change                       Revenue $29.5   $44.8   (34)%   $121.6   $116.3   5%                       Technology,...

Continue reading

Netskope Announces Strong Fourth Quarter and Fiscal Year 2026 Financial Results

ARR increased 31% year-over-year to $811 million Q4 revenue increased 32% year-over-year to $196.3 million Q4 net cash provided by operating activities was $18.1 million, representing 9% of revenueSANTA CLARA, Calif., March 11, 2026 (GLOBE NEWSWIRE) — Netskope, Inc. (NASDAQ:NTSK) a leader in modern security and networking for the cloud and AI era, today announced financial results for the fourth quarter and fiscal year 2026, ended January 31, 2026. “We closed fiscal 2026 on a strong note, delivering record net new ARR in Q4 and achieving our first full year of positive free cash flow,” said Sanjay Beri, CEO of Netskope. “The AI Supercycle is here, demanding a new standard for high-performance security and networking. We believe the next decade will be defined by an intelligent edge. Our Netskope One platform combined with our...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.